Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL BLOOD GLUCOSE MONITORING DEVICES MARKET WAS VALUED AT USD 25.62 BILLION IN 2023 AND IS EXPECTED TO REACH USD 52.46 BILLION BY 2029, GROWING AT A CAGR OF 12.69% DURING THE FORECAST PERIOD.
The Blood Glucose Monitoring Devices Market Size, Share & Trend Analysis Report By
- Product Type: Conventional Blood Glucose Monitoring Devices and Continuous Glucose Monitoring (CGM) Devices
- Conventional Blood Glucose Monitoring Devices: Test Strips, Meter & Software, and Lancet & Lancing Devices
- Continuous Glucose Monitoring (CGM) Devices: Sensors and Reusable Hardware
- Usage: Personal BGM Devices and Professional BGM Devices
- Distribution Channel: Offline and Online
- End-Users: Individuals, Hospitals & Clinics, and Other End-users
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
BLOOD GLUCOSE MONITORING DEVICES MARKET REPORT SCOPE
REPORT ATTRIBUTE | DETAILS |
---|---|
Market Size (2029) | USD 52.46 Billion |
Market Size (2023) | USD 25.62 Billion |
CAGR (2023-2029) | 12.69% |
HISTORIC YEAR | 2020-2022 |
BASE YEAR | 2023 |
FORECAST YEAR | 2024-2029 |
MARKET SEGMENTS BY | Product Type, Conventional Blood Glucose Monitoring Devices, Continuous Glucose Monitoring (CGM) Devices, Usage, Distribution Channel, End-Users, and Geography |
GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
KEY PLAYERS | F. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia Diabetes Care Holdings AG, and LifeScan IP Holdings |
MARKET INSIGHTS
The global blood glucose monitoring devices market was valued at USD 25.62 billion in 2023 and is expected to reach USD 52.46 billion by 2029, growing at a CAGR of 12.69% during the forecast period. The market is growing steadily and is expected to grow similarly during the forecast period. The surge in the market growth is attributed to the increasing prevalence/incidence of diabetes. In addition, there is an increased prevalence of chronic diseases across the globe. The rise in obesity cases also adds up to the diabetic population. Furthermore, technological advancements continue to advance new types of BGM launched, and government initiatives fuel the market growth.
A blood glucose monitoring device (BGM) is a small and portable medical device used to analyze blood glucose levels in diabetes management. Currently, two types of BGM devices are available on the market: conventional BGM and continuous glucose monitors (CGM). Blood glucose monitoring is considered the most essential factor in diabetes management.
MARKET TRENDS & DRIVERS
Next-generation Blood Glucose Monitoring Systems
Diabetes become the leading cause of death; so far, there are no effective treatments to prevent and cure diabetes, so reasonable blood glucose monitoring devices become a major choice. It led to continued innovation in these solutions, which created huge market growth opportunities. Optical sensor development is a recent innovation reported in blood glucose monitoring devices. Optical measurement technology has promising potential for glucose sensing, such as non-invasive measurement technology that helps to detect photons rather than electrons. Optical sensors receive more attention on the continuous quantification of glucose molecules.
Flash Glucose Monitoring an Emerging Trend In BGM Devices
In diabetes management, flash glucose monitoring (FGM) is one of the emerging trends that has become more popular in recent years and is expected to become a major choice in the future. It is a type of CGM. This device records body glucose readings throughout the day and night and displays the glucose level after scanning. This new solution gives advanced control over when and how often a person needs to check their glucose. Some recent studies have shown that patients with high derangements in glucose levels show significant clinical and novel changes with flash glucose monitoring technology.
Recent Government Initiatives Towards Diabetes Management with BGM
Globally, responding to the rapidly increasing burden of diabetes, several government initiatives and supportive programs have driven the demand for BGM devices. Government initiatives and public health campaigns are crucial in educating people about diabetes management and encouraging people to use self-monitoring devices. The World Health Organization launched the Global Diabetes Compact program with the Government of Canada, with the support of the University of Toronto. In India, the National Program for Prevention of Cancer, Diabetes, Cardiovascular Diseases, and Stroke and Indian health program campaigns support and educate people in India to increase the use of self-monitoring devices in diabetes management. Apart from that, the challenges and limitations associated with BGM devices, the high cost of blood glucose monitoring devices, and the large pool of undiagnosed people are some of the challenges to the market growth.
INDUSTRY RESTRAINTS
INSIGHTS BY PRODUCT TYPE
The global blood glucose monitoring devices market by product type is segmented into conventional blood glucose monitoring BGM devices (test strips, meter & software, lancet & lancing devices) and continuous glucose monitoring CGM devices (sensors, reusable hardware). Conventional blood glucose monitoring devices dominate and have the largest market share. They have a long history and familiarity with patients and healthcare settings. BGM is the most common practice in monitoring blood glucose in diabetic patients and is suggested by health authorities worldwide. BGM devices are cost-effective with or without insurance compared to CGM devices. It led to a high intake of BGM over CGM. The total cost of test strips and BGM devices is far lower than that of CGM systems. Furthermore, the growth in the self-monitoring blood glucose monitoring approach accelerates the market growth. BGM offers personalized treatment and management for a significant diabetes population. BGM offers immediate results, and this helps to adjust insulin dosage on time and effectively.
INSIGHTS BY USAGE
The global blood glucose monitoring devices market by usage is categorized into personal BGM devices and professional BGM devices. Personal BGM devices show significant growth, with the fastest-growing CAGR during the forecast period. The personal BGM usage has become a part of the regular management plans for the patients with diabetes. This helps patients appropriately schedule food, activity, and medication. Lack of regular SMBG predicts hospitalization for diabetes-related complications. This has compelled people to monitor blood glucose regularly and has increased drastically among insulin-using patients. This is especially true among type I diabetic patients, who must measure their blood glucose level at least three times a day to manage their health significantly. The prevalence of diabetes and changes in lifestyle with constant urbanization in developing countries have increased risk factors causing diabetes. Patients keep monitoring themselves to control their blood glucose level fluctuations. These factors widely contribute to segmental growth.
INSIGHTS BY DISTRIBUTION CHANNEL
The offline store accounted for the largest global blood glucose monitoring devices market share based on the distribution channel. Offline stores are the primary point-of-care for BGM devices in developed and developing markets. In addition, in developing countries, offline stores such as pharmacies, retail drug stores, and health and wellness stores are considered major sources of diabetes care solutions. The offline store segment includes hospital pharmacies, standalone pharmacies, and other drug and medical devices selling stores. The retail stores are one of the oldest distribution channels. Hospital-owned pharmacies, standalone pharmacies, and drug houses are the major contributors to the retail chain distribution of BGM devices.
INSIGHTS BY END-USERS
Based on the end-users, the individual segment shows the highest global blood glucose monitoring devices market growth during the forecast period. Diabetes is a global public health crisis that threatens the economies of all nations, particularly developing countries. Morbidity and mortality from diabetes are extremely high in poor countries due to poor management and noncompliance with global guidelines. Many studies have observed that individuals lacking diabetes management face extremely poor outcomes. This has made diabetic patients undergo self-testing frequently. Screening for diabetes in large populations living in diverse habitats may not be cost‐effective. The cost of diagnostic tests and scarcity of health staffing pose a large hurdle in diagnosis and monitoring patients in developed and developing countries. To counter these challenges, patients have shifted to self-monitoring blood glucose devices. Governments reimburse these devices, which insurance covers, thus helping segmental growth.
GEOGRAPHICAL ANALYSIS
North America accounted for the largest share of 44% in the global blood glucose monitoring devices market. The region is a highly developed market for BMG devices. In terms of R&D, advances in BGM devices, high expenditure on diabetes care and management, and government initiatives are some factors that fuel the market growth in the region. Moreover, the available health insurance and reimbursement policies for diabetes management and the government focus on diabetes care management increase the access to BGM devices among type 1 & 2 diabetic patients in the region, which propels significant market growth.
VENDOR LANDSCAPE
The global blood glucose monitoring devices market report contains exclusive data on 40 vendors. The market is highly fragmented. Major players dominate the market. However, there are moderate growth opportunities for new entrants. Though the market is dominated by major players, many investigational and small companies are coming into existence with blood glucose monitoring devices. F. Hoffmann-La Roche, Abbott, Dexcom, Medtronic, Ascensia Diabetes Care Holdings AG, and LifeScan IP Holdings are some leading companies dominating the conventional BGM devices segment. These players accounted for a significant market share in the global blood glucose monitoring devices market. These vendors are continuously developing and investing in BGM devices and tools and are expected to dominate the market with continued engagement.
Recent Vendors Activities
- In 2024, MTD Group acquired the pen needle and blood glucose monitoring systems of Ypsomed, as well as announced significant investment for its European product sites.
- In 2023, Abbott acquired Bigfoot Biomedical, one of the leading manufacturers of smart insulin management systems. This transaction strengthened Abbott's FreeStyle Libre CGM technology, helping it increase its presence in diabetes care.
- In 2023, Medtronic entered into a set of definitive agreement to acquire EoFlow Co. Ltd., a pioneer in insulin delivery devices. Medtronic’s meal detection technology algorithm and next-generation CGM are expected to expand the company’s ability to deliver diabetes care solutions.
- In 2022, Abbott collaborated with Sugar.fit, BeatO, Zyla Health, 1MG, PharmEasy, GOQii, Helthifyme, and Fitterfly to expand access to diabetes management care. Through this collaboration, Abbott aims to offer glucose monitoring solutions to around 8 billion people with diabetes. More than 6.5 billion people receive these solutions through PharmEasy and 1MG.
- In 2022, embecta and Intuity Medical made a commercial collaboration to promote POGO -Automatic Blood Glucose Monitoring systems to medical professionals across the US.
- In 2020, One Drop, a diabetes management company, acquired assets, IP, and certain Staff of Sano Intelligence, which manufactured noninvasive connected CGM Patches.
Product Launched & Development
- In June 2024, Prevounce Health launched a technologically advanced, cellular-connected blood glucose meter for remote patient monitoring. It is a rigorously tested and FDA-approved device widely available in the US and global markets.
- In June 2024, the US FDA approved Abbott’s two over-the-counter continuous glucose monitoring devices, Libre Rio and Lingo, which are used by more than 6 million globally.
- In May 2024, Smart Meter launched an iGlucose Plus glucose monitoring device globally. It is a handheld device connected to a smartphone and Wi-Fi systems.
- In Feb 2024, Dexcom launched Dexcom ONE+, a real-time and customized glucose monitoring device that can be worn in three different body locations. Furthermore, it has a water-resistant sensor that enhances its brand image.
- In February 2024, Know Labs launched KnowU, a wearable and non-invasive continuous glucose monitoring device with onboard computing power and machine learning technologies.
- In January 2022, Roche launched a smart, handheld, and point-of-care blood glucose monitor for hospital bedside use.
Frequently Asked Questions
How big is the global blood glucose monitoring devices market?
What is the growth rate of the global blood glucose monitoring devices market?
Who are the major players in the global blood glucose monitoring devices market?
Which region dominates the global blood glucose monitoring devices market?
The global blood glucose monitoring devices market size is expected to grow at a CAGR of approximately 12.69% from 2023 to 2029.
Base Year: 2023
Forecast Year: 2024-2029
The report considers the present scenario of the global blood glucose monitoring devices and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
VENDORS LIST
Key Vendors
- F. Hoffmann-La Roche
- Business Overview
- Product Offerings
- Abbott
- Dexcom
- Medtronic
- Ascensia Diabetes Care Holdings AG
- LifeScan IP Holdings
Other Prominent Vendors
- Arkray
- Business Overview
- Product Offerings
- ApexBio
- ACON Laboratories, Inc.
- AgaMatrix
- Alliance International
- Andon Health
- Bionime
- Beurer
- Bioptik
- BioTelemetry
- BioTest Medical
- BTNX
- DarioHealth
- EASYMAX
- ForaCare
- Hannox International
- Integrity Applications
- i-SENS
- MED TRUST
- Medisana
- Nova Biomedical
- Omnis Health
- Nemaura
- OK Biotech
- OSANG Healthcare
- Philosys
- Sanofi
- Taidoc Technology
- Terumo Corporation
- Trividia Health
- Rossmax International
- Ypsomed
- 77 Electronika Kft
- Menarini Diagnostics
SEGMENTATION & FORECAST
- By Product Type
- Conventional Blood Glucose Monitoring Devices
- Continuous Glucose Monitoring (CGM) Devices
- By Conventional Blood Glucose Monitoring Devices
- Test Strips
- Meter & Software
- Lancet & Lancing Devices
- By Continuous Glucose Monitoring (CGM) Devices
- Sensors
- Reusable Hardware
- By Usage
- Personal BGM Devices
- Professional BGM Devices
- By Distribution Channel
- Offline
- Online
- By End-Users
- Individuals
- Hospitals & Clinics
- Other End-users
- By Geography
- North America
- The U.S.
- Canada
- Europe
- Germany
- The U.K.
- France
- Italy
- Spain
- APAC
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Columbia
- Argentina
- Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
Exhibit 1: Projected Revenues of Blood Glucose Monitoring Devices Market in Global (2020 – 2029; $ BN)
Exhibit 2: Market Size & Forecast – Conventional BGM Devices (2020 – 2029; $ BN)
Exhibit 3: Market Size & Forecast – Test Strips (2020 – 2029; $ BN)
Exhibit 4: Market Size & Forecast – Meter & Software (2020 – 2029; $ BN)
Exhibit 5: Market Size & Forecast – Lancet & Lancing Devices (2020 – 2029; $ BN)
Exhibit 6: Market Size & Forecast – Continuous Glucose Monitoring Devices (2020 – 2029; $ BN)
Exhibit 7: Market Size & Forecast – Sensors (2020 – 2029; $ BN)
Exhibit 8: Market Size & Forecast – Reusable Hardware (2020 – 2029; $ BN)
Exhibit 9: Market Size & Forecast – Personal BGM Devices (2020 – 2029; $ BN)
Exhibit 10: Market Size & Forecast – Professional BGM Devices (2020 – 2029; $ BN)
Exhibit 11: Market Size & Forecast – Offline Stores (2020 – 2029; $ BN)
Exhibit 12: Market Size & Forecast – Online Stores (2020 – 2029; $ BN)
Exhibit 13: Market Size & Forecast – Individuals (2020 – 2029; $ BN)
Exhibit 14: Market Size & Forecast – Hospitals & Clinics (2020 – 2029; $ BN)
Exhibit 15: Market Size & Forecast – Other End-user (2020 – 2029; $ BN)
Exhibit 16: Projected Revenues of Blood Glucose Monitoring Devices Market in N. America (2020 – 2029; $ BN)
Exhibit 17: Projected Revenues of Blood Glucose Monitoring Devices Market in the US (2020 – 2029; $ BN)
Exhibit 18: Projected Revenues of Blood Glucose Monitoring Devices Market in Canada (2020 – 2029; $ BN)
Exhibit 19: Projected Revenues of Blood Glucose Monitoring Devices Market in Europe (2020 – 2029; $ BN)
Exhibit 20: Projected Revenues of Blood Glucose Monitoring Devices Market in Germany (2020 – 2029; $ BN)
Exhibit 21: Projected Revenues of Blood Glucose Monitoring Devices Market in France (2020 – 2029; $ BN)
Exhibit 22: Projected Revenues of Blood Glucose Monitoring Devices Market in the UK (2020 – 2029; $ BN)
Exhibit 23: Projected Revenues of Blood Glucose Monitoring Devices Market in Italy (2020 – 2029; $ BN)
Exhibit 24: Projected Revenues of Blood Glucose Monitoring Devices Market in Spain (2020 – 2029; $ BN)
Exhibit 25: Projected Revenues of Blood Glucose Monitoring Devices Market in APAC (2020 – 2029; $ BN)
Exhibit 26: Projected Revenues of Blood Glucose Monitoring Devices Market in China (2020 – 2029; $ BN)
Exhibit 27: Projected Revenues of Blood Glucose Monitoring Devices Market in Japan (2020 – 2029; $ BN)
Exhibit 28: Projected Revenues of Blood Glucose Monitoring Devices Market in India (2020 – 2029; $ BN)
Exhibit 29: Projected Revenues of Blood Glucose Monitoring Devices Market in South Korea (2020 – 2029; $ BN)
Exhibit 30: Projected Revenues of Blood Glucose Monitoring Devices Market in Australia (2020 – 2029; $ BN)
Exhibit 31: Projected Revenues of Blood Glucose Monitoring Devices Market in L. America (2020 – 2029; $ BN)
Exhibit 32: Projected Revenues of Blood Glucose Monitoring Devices Market in Brazil (2020 – 2029; $ BN)
Exhibit 33: Projected Revenues of Blood Glucose Monitoring Devices Market in Mexico (2020 – 2029; $ BN)
Exhibit 34: Projected Revenues of Blood Glucose Monitoring Devices Market in Colombia (2020 – 2029; $ BN)
Exhibit 35: Projected Revenues of Blood Glucose Monitoring Devices Market in Argentina (2020 – 2029; $ BN)
Exhibit 36: Projected Revenues of Blood Glucose Monitoring Devices Market in MEA (2020 – 2029; $ BN)
Exhibit 37: Projected Revenues of Blood Glucose Monitoring Devices Market in Turkey (2020 – 2029; $ BN)
Exhibit 38: Projected Revenues of Blood Glucose Monitoring Devices Market in South Africa 2020 – 2029; $ BN)
Exhibit 39: Projected Revenues of Blood Glucose Monitoring Devices Market in Saudi Arabia (2020 – 2029; $ BN)
Tables
Table 1: Estimated & Projected Revenues of Blood Glucose Monitoring Devices in Global (2020 – 2029; $ Bn)
Table 2: Market Size & Forecast Blood Glucose Monitoring Devices Market by Product Type (2020 – 2029; $ Bn)
Table 3: Market Size & Forecast Blood Glucose Monitoring Devices Market by Product Type (2020 – 2029; %)
Table 4: Market Size & Forecast Conventional BGM Devices Market by Product Type (2020 – 2029; $ Bn)
Table 5: Market Size & Forecast Conventional BGM Devices Market by Product Type (2020 – 2029; %)
Table 6: Market Size & Forecast CGM Devices Market by Product Type (2020 – 2029; $ Bn)
Table 7: Market Size & Forecast CGM Devices Market by Product Type (2020 – 2029; $ %)
Table 8: Market Size & Forecast Blood Glucose Monitoring Devices Market by Usage (2020 – 2029; $ Bn)
Table 9: Market Size & Forecast Blood Glucose Monitoring Devices Market by Usage (2020 – 2029; %)
Table 10: Market Size & Forecast Blood Glucose Monitoring Devices Market by Dist. Channels (2020 – 2029; $ Bn)
Table 11: Market Size & Forecast Blood Glucose Monitoring Devices Market by Dist. Channels (2020 – 2029; %)
Table 12: Market Size & Forecast Blood Glucose Monitoring Devices Market by End-user (2020 – 2029; $ Bn)
Table 13: Market Size & Forecast Blood Glucose Monitoring Devices Market by End-user (2020 – 2029; %)
Table 14: Market Size & Forecast Blood Glucose Monitoring Devices Market by Geography(2020 – 2029; $ Bn)
Table 15: Market Size & Forecast Blood Glucose Monitoring Devices Market by Geography(2020 – 2029; %)
CHAPTER – 1: Blood Glucose Monitoring Devices Market Overview
- Executive Summary
- Key Findings
CHAPTER – 2: Blood Glucose Monitoring Devices Market Market
- GLOBAL: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)
CHAPTER – 3: Blood Glucose Monitoring Devices Market Prospects & Opportunities
- Blood Glucose Monitoring Devices Market Opportunities & Trends
- Blood Glucose Monitoring Devices Market Drivers
- Blood Glucose Monitoring Devices Market Constraints
CHAPTER – 4: Blood Glucose Monitoring Devices Market Segmentation Data
- GLOBAL: Projected Revenue by Product Type (2020-2029; $ Billions)
- Conventional Blood Glucose Monitoring Devices
- Test Strips
- Meter & Software
- Lancet & Lancing Devices
- Continuous Glucose Monitoring (CGM) Devices
- Sensors
- Reusable Hardware
- GLOBAL: Projected Revenue by Usage (2020-2029; $ Billions)
- Personal BGM Devices
- Professional BGM Devices
- GLOBAL: Projected Revenue by Distribution Channels (2020-2029; $ Billions)
- Offline Stores
- Online Stores
- GLOBAL: Projected Revenue by End-user (2020-2029; $ Billions)
- Individuals
- Hospitals & Clinics
- Other End-user
CHAPTER – 5: Key Regions Overview
- North America: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)
- Projected Revenue of Blood Glucose Monitoring Devices Market in the US
- Projected Revenue of Blood Glucose Monitoring Devices Market in Canada
- Europe: Projected Revenue of Blood Glucose Monitoring Devices (2020-2029; $ Billions)
- Projected Revenue of Blood Glucose Monitoring Devices Market in Germany
- Projected Revenue of Blood Glucose Monitoring Devices Market in France
- Projected Revenue of Blood Glucose Monitoring Devices Market in the UK
- Projected Revenue of Blood Glucose Monitoring Devices Market in Italy
- Projected Revenue of Blood Glucose Monitoring Devices Market in Spain
- APAC: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)
- Projected Revenue of Blood Glucose Monitoring Devices Market in China
- Projected Revenue of Blood Glucose Monitoring Devices Market in Japan
- Projected Revenue of Blood Glucose Monitoring Devices Market in India
- Projected Revenue of Blood Glucose Monitoring Devices Market in South Korea
- Projected Revenue of Blood Glucose Monitoring Devices Market in Australia
- Latin America: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)
- Projected Revenue of Blood Glucose Monitoring Devices Market in Brazil
- Projected Revenue of Blood Glucose Monitoring Devices Market in Mexico
- Projected Revenue of Blood Glucose Monitoring Devices Market in Colombia
- Projected Revenue of Blood Glucose Monitoring Devices Market in Argentina
- Middle East & Africa: Projected Revenue of Blood Glucose Monitoring Devices Market (2020-2029; $ Billions)
- Projected Revenue of Blood Glucose Monitoring Devices Market in Turkey
- Projected Revenue of Blood Glucose Monitoring Devices Market in South Africa
- Projected Revenue of Blood Glucose Monitoring Devices Market in Saudi Arabia
CHAPTER – 6:Blood Glucose Monitoring Devices Market Industry Overview
- Blood Glucose Monitoring Devices Market – Competitive Landscape
- Blood Glucose Monitoring Devices Market– Key Vendor Profiles
- Blood Glucose Monitoring Devices Market– Other Prominent Vendors
- Blood Glucose Monitoring Devices Market – Key Strategic Recommendations
CHAPTER – 7: Appendix
- Research Methodology
- Abbreviations
- About Arizton
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the global blood glucose monitoring devices market?
What is the growth rate of the global blood glucose monitoring devices market?
Who are the major players in the global blood glucose monitoring devices market?
Which region dominates the global blood glucose monitoring devices market?